Literature DB >> 15482557

Validity of a self-reported history of a positive tuberculin skin test. A prospective study of drug users.

Hillary V Kunins1, Andrea A Howard, Robert S Klein, Julia H Arnsten, Alain H Litwin, Ellie E Schoenbaum, Marc N Gourevitch.   

Abstract

OBJECTIVE: To define the prevalence of and factors associated with having a negative purified protein derivative (PPD) among persons who self-report a prior positive PPD and to define the safety of repeat testing in such persons.
DESIGN: Observational cohort study.
SETTING: Methadone maintenance program with onsite primary care. PATIENTS/PARTICIPANTS: Current or former drug users enrolled in methadone maintenance treatment.
INTERVENTIONS: Structured interview, tuberculin skin testing regardless of self-reported PPD status, and anergy testing.
MEASUREMENTS AND MAIN RESULTS: Nearly one third (31%) of participants who self-reported a prior positive PPD had a negative measured PPD, despite receipt of a "booster" PPD. A single participant (0.5%) blistered in response to the PPD without lasting ill effect. Participants with PPD results discordant from their history were more likely to be HIV-seropositive and nonreactive to the anergy panel. The discordance rate among HIV-infected participants was 43%, and was largely attributable to immune dysfunction. Among HIV-seronegative participants, the discordance rate was 27%. Recent crack-cocaine use was independently associated with discordance in the absence of HIV infection.
CONCLUSIONS: We confirmed that planting a PPD in patients who self-report a positive PPD history confers minimal risk. Substantial rates of discordance exist between self-reported history of a positive PPD and measured PPD status. Further research is needed to define the optimal management of PPD-negative patients who self-report a prior positive PPD and who have not received prior treatment for latent tuberculosis.

Entities:  

Mesh:

Year:  2004        PMID: 15482557      PMCID: PMC1492579          DOI: 10.1111/j.1525-1497.2004.30424.x

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN: 0884-8734            Impact factor:   5.128


  23 in total

1.  Concurrence of drug users' self-report of current HIV status and serotest results.

Authors:  S M Strauss; D M Rindskopf; S Deren; G P Falkin
Journal:  J Acquir Immune Defic Syndr       Date:  2001-07-01       Impact factor: 3.731

2.  Prevalence and risk factors for positive tuberculin skin tests among active drug users at a syringe exchange program.

Authors:  N Salomon; D C Perlman; P Friedmann; V Ziluck; D C Des Jarlais
Journal:  Int J Tuberc Lung Dis       Date:  2000-01       Impact factor: 2.373

3.  The stability of the tuberculin reaction.

Authors:  S KUNOFSKY; J KATZ
Journal:  Am Rev Tuberc       Date:  1958-12

4.  Crack cocaine use and other risk factors for tuberculin positivity in drug users.

Authors:  Andrea A Howard; Robert S Klein; Ellie E Schoenbaum; Marc N Gourevitch
Journal:  Clin Infect Dis       Date:  2002-10-25       Impact factor: 9.079

5.  Hepatitis C disease among injection drug users: knowledge, perceived risk and willingness to receive treatment.

Authors:  M D Stein; J Maksad; J Clarke
Journal:  Drug Alcohol Depend       Date:  2001-02-01       Impact factor: 4.492

6.  A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. HER Study Group. HIV Epidemiology Research.

Authors:  R S Klein; D Smith; J Sobel; T Flanigan; J B Margolick
Journal:  Int J Tuberc Lung Dis       Date:  2000-07       Impact factor: 2.373

7.  Detection of latent tuberculosis among HIV-infected patients after initiation of highly active antiretroviral therapy.

Authors:  Tamara L Fisk; Hui-Ming Hon; Jeffrey L Lennox; C Fordham von Reyn; C Robert Horsburgh
Journal:  AIDS       Date:  2003-05-02       Impact factor: 4.177

8.  Isoniazid hepatotoxicity among drug users: the role of hepatitis C.

Authors:  Alberto Fernández-Villar; Bernardo Sopeña; Rafael Vázquez; Fernando Ulloa; Enrique Fluiters; Mar Mosteiro; César Martínez-Vázquez; Luis Piñeiro
Journal:  Clin Infect Dis       Date:  2003-01-15       Impact factor: 9.079

9.  Risk factors for human immunodeficiency virus infection in intravenous drug users.

Authors:  E E Schoenbaum; D Hartel; P A Selwyn; R S Klein; K Davenny; M Rogers; C Feiner; G Friedland
Journal:  N Engl J Med       Date:  1989-09-28       Impact factor: 91.245

10.  Tuberculosis knowledge among New York City injection drug users.

Authors:  H Wolfe; M Marmor; R Maslansky; S Nichols; M Simberkoff; D Des Jarlais; A Moss
Journal:  Am J Public Health       Date:  1995-07       Impact factor: 9.308

View more
  1 in total

Review 1.  Tuberculosis and illicit drug use: review and update.

Authors:  Robert G Deiss; Timothy C Rodwell; Richard S Garfein
Journal:  Clin Infect Dis       Date:  2009-01-01       Impact factor: 9.079

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.